Open Label, Randomized, 6-sequence Crossover Study to Evaluate the Drug-drug Interaction Between Montelukast Sodium and Levocetirizine Dihydrochloride in Healthy Male Volunteers.

Trial Profile

Open Label, Randomized, 6-sequence Crossover Study to Evaluate the Drug-drug Interaction Between Montelukast Sodium and Levocetirizine Dihydrochloride in Healthy Male Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Dec 2013

At a glance

  • Drugs Levocetirizine/montelukast (Primary) ; Levocetirizine; Montelukast
  • Indications Allergic asthma; Allergic rhinitis; Dermatitis; Perennial allergic rhinitis; Pruritus; Seasonal allergic rhinitis; Urticaria
  • Focus Pharmacokinetics
  • Acronyms HM-MOLZ101; MOLZ
  • Sponsors Hanmi Pharmaceutical
  • Most Recent Events

    • 01 Jan 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Jan 2012 New source identified and integrated (Korean Clinical Trials Register: KCT0000303).
    • 17 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top